HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia. - Wikidata - awgldk - TriplyDB

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

http://www.wikidata.org/entity/Q37625289

about

Bosutinib as a fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia: A case report.Management of chronic myeloid leukemia in blast crisis.Management of advanced-phase chronic myeloid leukemia.Diagnosis and Treatment of Chronic Myeloid Leukemia in 2015.Management of Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Accelerated or Blastic Phase.How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety.Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.Transplantation from haploidentical donor is not inferior to that from identical sibling donor for patients with chronic myeloid leukemia in blast crisis or chronic phase from blast crisis.

P2860

Q33442587-05669194-0DCF-4ACF-BBE8-0590C35EE71A Q38392682-6E6015CB-8005-476C-92DD-86CC93AC5939 Q38452040-891D4AFB-0A8E-4056-8012-458632E4DABE Q38598820-0F97D5B5-F84D-4EFC-861D-567DCBFFDBCE Q38767908-C95A973E-1662-49FC-B711-C96324ACFD8D Q38845834-1E727262-0A17-4F4E-8FAE-04D9AD51E491 Q48029219-C64F3B5B-1FB4-427A-95B0-F7F6AF240BCE Q53082542-38D18026-74E5-41D9-9702-FCF806EDB19A

P2860

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

http://www.wikidata.org/entity/Q37625289

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 22 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

@en

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

@nl

type

label

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

@en

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

@nl

prefLabel

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

@en

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

@nl

P1433

Q37625289-CC73E2F0-4B20-4569-ADA4-95A11CA42B53

P1476

Q37625289-51898166-B6AB-41E7-97A0-F1F0056605A0

P2093

Q37625289-78A39044-7284-4DD9-84FF-4570EE97AEFA

Q37625289-7BBE69C3-D9AD-4024-A6BE-890B10DB40EF

Q37625289-8AEB116C-150A-4612-8315-564C0BE40CC4

Q37625289-ACAAF58E-B091-4800-81B2-B029F2C3E267

Q37625289-D13CBB12-5D38-4B8C-ADD0-C3C8DFCD5886

Q37625289-ECB3C68B-FDC9-4AA9-8BD0-004803534EE5

P2860

Q37625289-0309FD87-046F-4E08-8D4C-C07CF4448601

Q37625289-103FED76-7949-4578-B0A7-322AE0428A32

Q37625289-11F2AD8E-7AB4-4A7E-A109-7B70BA2F7D33

Q37625289-139DA365-ED59-4A0F-B8DB-93FA2E91EDE7

Q37625289-4023F982-602D-43D2-8648-3AE5127EFA06

Q37625289-45862C7C-3BC5-4C75-88ED-9B6972020AC1

Q37625289-6ACDF41B-FD2F-4F1D-803D-92CE728C5502

Q37625289-6F4F7836-31A0-4BD6-ADFA-388C33F0926C

Q37625289-75B5CB05-71B3-44F3-9192-B0D60CE560D9

Q37625289-89A09035-6BF4-41FA-A8E9-F1785C7D0857

P304

Q37625289-E31AC344-5F73-4D83-9C62-E71A52A9BF0C

P31

Q37625289-FC26E0E0-42EF-40B5-B24A-02CB8F8EC0CA

P356

Q37625289-1CEC37B5-DC60-4214-9230-7D4704CC320C

P407

Q37625289-2C4CD7FC-D176-4856-A231-E735E6FA9C11

P433

Q37625289-02AAA825-319D-440A-BB68-C2F8BA6A159E

P478

Q37625289-16D59F77-060D-47AE-AB12-4D0795DF7BDA

P50

Q37625289-0BE71EB2-ABFA-4DC6-BFC0-13E442E8A9DB

Q37625289-527A277B-947E-456C-856E-CC1217603211

Q37625289-737CD851-D92C-4963-B37F-EB2D30868997

Q37625289-C306E9BA-104B-4E82-99C9-B993B212B772

Q37625289-D2C01AF1-B427-4659-BE62-90AE39FB57A9

Q37625289-DB837CDC-CF2F-4276-AC97-CE2AF1473362

Q37625289-E19C02D6-0746-4FF3-9A4F-9787971CE699

Q37625289-EB8DEED9-51AF-4660-AC5B-489CDA08550B

P577

Q37625289-A897E25A-E7B9-4CCF-9895-C973E954E213

P698

Q37625289-88879D07-BD17-4770-86D9-209D3EAD7E17

P921

Q37625289-C6BE580F-132C-4BFC-8CD3-8A37BF0F61D5

Q37625289-D1182CF8-81DC-4DC6-A483-1CD931CBF325

P932

Q37625289-948DA355-02CF-4CFA-B939-DE28606907F9

P356

P1433

P1476

HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

@en

P2093

Deborah Thomas

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Jorgensen

http://www.w3.org/2001/XMLSchema#string

Lynne Abruzzo

http://www.w3.org/2001/XMLSchema#string

Paolo Strati

http://www.w3.org/2001/XMLSchema#string

Raja Luthra

http://www.w3.org/2001/XMLSchema#string

Sergej Konoplev

http://www.w3.org/2001/XMLSchema#string

P2860

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION).

First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia.

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

Blastic phase of chronic myelogenous leukemia.

Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.

Pathobiology of lymphoid and myeloid blast crisis and management issues.

Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance

P304

373-380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.28433

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Jorge Eduardo Cortes

Hagop Kantarjian

Gautam Borthakur

Alfonso Quintas-Cardama

P577

2013-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24151050

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

3946911

http://www.w3.org/2001/XMLSchema#string